Guangtai Vacuum's second IPO review at Beijing Stock Exchange approved

LightningPacketLoss · 2026-03-30T11:56:40+00:00

Shenyang Guangtai Vacuum Technology Co., Ltd. successfully passed the IPO listing review on the evening of March 26. The company specializes in the research, development, and manufacturing of vacuum equipment, with integrated capabilities. Although the review was temporarily deferred during the meeting on December 29, 2025, it was approved smoothly this time. During the listing meeting, committee members raised questions regarding the timing of revenue recognition.

LightningPacketLoss

2026-03-30 11:56:40

Abstract generation in progress

Beijing Business Today News (reporters Ma Huanhuan and Li Jiaxue) On the evening of March 26, the Beijing Stock Exchange website showed that Shenyang Guangtai Vacuum Technology Co., Ltd. (hereinafter referred to as “Guangtai Vacuum”)’s IPO on the same day was approved at the meeting.

It is understood that Guangtai Vacuum is a high-tech enterprise focusing on the R&D, manufacturing, and sales of vacuum equipment, and it also has an integrated capability from independently designing equipment to manufacturing and delivery. In addition, on December 29, 2025, Guangtai Vacuum was scheduled to be considered at the meeting, but the review was postponed; this time is the company’s second attempt to be considered.

At the venue of the Listing Committee meeting, regarding the accuracy of the revenue recognition timing, the Listing Committee required Guangtai Vacuum to explain the reasons and reasonableness for the fact that, during the reporting period, the timing of when goods were delivered exceeded 1 year, but customers had not completed acceptance for a long time; whether there are contract disputes or legal issues; and whether the accounting treatment of the relevant transactions complies with the provisions of accounting standards.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.